idiotype-pulsed allogeneic dendritic cells
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2002 (NCT00988312)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous idiotype-protein pulsed dendritic cells
- idiotype-pulsed allogeneic dendritic cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00186316 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2003 | National Cancer Institute (NCI), Stanford University |
| NCT00988312 | Phase 1 | Mar 1, 2002 | Technical University of Dresden |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2003 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Technical University of Dresden | Academic/Hospital | 1 | 1 | 1 | 2002 |
3 organizations
Page 1 / 1